Imarikiren hydrochloride

N/A

Report date: 2022/04/28 14:26:30
NME

Base Information

Drug NameImarikiren hydrochloride
Drug Alias NameImarikirenTAK-272SCO-272
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRenin inhibitors
TargetsRenin
Therapy Area/IndicationsHypertensionRenal InsufficiencyDiabetic Nephropathies +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesScohia Pharma Inc
Active IndicationsHypertensionDiabetic Nephropathies
Inactive IndicationsRenal InsufficiencyHepatic Insufficiency

Other Information

ATC CodeN/A
Related LinksN/A